Search Results - "Tauziède-Espariat, Arnault"

Detection of GJA4 Mutation in a Sinonasal Angioleiomyoma.

Authors: Tauziède-Espariat, Arnault Saffroy, Raphaël Lecler, Augustin et al.

Source: Case Reports in Pathology. 3/16/2026, Vol. 2026, p1-4. 4p.

CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.

Authors: Tauziède-Espariat, Arnault Lew-Derivry, Lucille Abbou, Samuel et al.

Source: Acta Neuropathologica Communications. 1/19/2024, Vol. 12 Issue 1, p1-5. 5p.

Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype.

Authors: Tauziède-Espariat, Arnault Friker, Lea L. Nussbaumer, Gunther et al.

Source: Acta Neuropathologica Communications. 11/18/2024, Vol. 12 Issue 1, p1-11. 11p.

Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome.

Authors: Tauziède-Espariat, Arnault Simbozel, Marie Sievers, Philipp et al.

Source: Acta Neuropathologica Communications. 1/16/2025, Vol. 13 Issue 1, p1-5. 5p.

Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered.

Authors: Tauziède-Espariat, Arnault Castel, David Ajlil, Yassine et al.

Source: Acta Neuropathologica Communications. 6/27/2024, Vol. 12 Issue 1, p1-4. 4p.

CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm.

Authors: Tauziède-Espariat, Arnault Figarella-Branger, Dominique Métais, Alice et al.

Source: Acta Neuropathologica Communications. 3/14/2023, Vol. 11 Issue 1, p1-4. 4p.

Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology.

Authors: Tauziède-Espariat, Arnault Guida, Lelio Dangouloff-Ros, Volodia et al.

Source: Acta Neuropathologica Communications. 6/26/2024, Vol. 12, p1-5. 5p.

A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma.

Authors: Tauziède-Espariat, Arnault Simbozel, Marie Liu, Anthony P. Y. et al.

Source: Acta Neuropathologica Communications. 4/3/2023, Vol. 11 Issue 1, p1-4. 4p.

Brain metastasis of a urothelial neuroendocrine carcinoma: A double pitfall for neuropathologists and DNA‐methylation profiling.

Authors: Tauziède‐Espariat, Arnault Masliah‐Planchon, Julien Tran, Suzanne et al.

Source: Neuropathology & Applied Neurobiology. Feb2024, Vol. 50 Issue 1, p1-6. 6p.

Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling.

Authors: Tauziède-Espariat, Arnault Masliah-Planchon, Julien Andrianteranagna, Mamy et al.

Source: Acta Neuropathologica Communications. 8/21/2023, Vol. 11 Issue 1, p1-4. 4p.

Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!

Authors: Tauziède-Espariat, Arnault Siegfried, Aurore Uro-Coste, Emmanuelle et al.

Source: Acta Neuropathologica Communications. 8/19/2022, Vol. 10 Issue 1, p1-4. 4p.

ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital.

Authors: Tauziède-Espariat, Arnault Roux, Alexandre Benzakoun, Joseph et al.

Source: Acta Neuropathologica Communications. 6/13/2025, Vol. 13 Issue 1, p1-10. 10p.

Glioneuronal tumors PATZ1-fused: clinico-molecular and DNA methylation signatures for a variety of morphological and radiological profiles.

Authors: Tauziède-Espariat, Arnault Dangouloff-Ros, Volodia Sievers, Philipp et al.

Source: Acta Neuropathologica Communications. 5/24/2025, Vol. 13 Issue 1, p1-12. 12p.

CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.

Authors: Tauziède-Espariat, Arnault Nicaise, Yvan Sievers, Philipp et al.

Source: Acta Neuropathologica Communications. 4/5/2024, Vol. 12 Issue 1, p1-14. 14p.

Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status.

Authors: Tauziède-Espariat, Arnault Uro-Coste, Emmanuelle Nicaise, Yvan et al.

Source: Acta Neuropathologica Communications. 10/24/2023, Vol. 11 Issue 1, p1-4. 4p.

CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.

Authors: Tauziède-Espariat, Arnault Uro-Coste, Emmanuelle Sievers, Philipp et al.

Source: Acta Neuropathologica Communications. 2/13/2023, Vol. 11 Issue 1, p1-7. 7p.

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome.

Authors: Guerrini-Rousseau, Léa Tauziède-Espariat, Arnault Castel, David et al.

Source: Acta Neuropathologica Communications. 1/6/2023, Vol. 11 Issue 1, p1-4. 4p.

A malignant choroid plexus tumour with prevailing immature blastematous elements.

Authors: Tauziède‐Espariat, Arnault Pagès, Mélanie Masliah‐Planchon, Julien et al.

Source: Neuropathology & Applied Neurobiology. Feb2022, Vol. 48 Issue 2, p1-3. 3p.

The malignant transformation of an atypical angiocentric glioma, MYB-altered.

Authors: Aboubakr, Oumaima Wefers, Annika K. Dangouloff-Ros, Volodia et al.

Source: Acta Neuropathologica Communications. 7/23/2025, Vol. 13 Issue 1, p1-5. 5p.

A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.

Authors: Tauziède-Espariat, Arnault Chotard, Guillaume le Loarer, François et al.

Source: Acta Neuropathologica Communications. 2/3/2022, Vol. 10 Issue 1, p1-5. 5p.